Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan National Yang-Ming University, Taipei, Taiwan.
National Yang-Ming University, Taipei, Taiwan Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Ann Rheum Dis. 2015 Jul;74(7):1347-52. doi: 10.1136/annrheumdis-2013-204832. Epub 2014 Feb 14.
To identify the incidence rate (IR) and risk factors of osteoporotic fractures (OFs) among systemic sclerosis (SSc) patients.
A cohort study was conducted using the Taiwan National Health Insurance database. Patients with SSc and respective age- and gender-matched controls without SSc were enrolled. The primary endpoint was the first occurrence of OF. The Cox proportional hazard model was used to investigate the risk factor of OFs in the SSc cohort.
Among 1712 SSc patients (77.8% female, mean age 50.3 years) with a median follow-up of 5.2 years, 54 patients developed vertebral fractures, 17 patients developed hip fractures, and 7 patients developed radius fractures (IR: 6.99, 2.18 and 0.90 per 1000 person-years, respectively). Compared with the controls, the incidence rate ratios (IRRs) (95% CIs) among SSc patients were 1.78 (1.30 to 2.39, p<0.001) for vertebral fractures and 1.89 (1.05 to 3.22, p=0.026) for hip fractures. The IRRs for overall OFs were 1.74 (1.32 to 2.27, p<0.001) for women and 1.06 (0.33 to 2.66, p=0.856) for men. The SSc patients experienced hip fractures at a younger age (67.2 vs 75.2 years, p=0.005), and had a higher 1-year mortality rate (13% vs 3%, p=0.006) of vertebral fractures than did the controls. Multivariable Cox regression analyses indicated that older age, being female, using daily prednisolone equivalent to >7.5 mg, and bowel dysmotility treated with intravenous metoclopramide are associated with OF.
SSc patients had a high IR of vertebral and hip fractures, especially those who were female, older, used a high dose of corticosteroid or experienced bowel dysmotility.
确定系统性硬化症(SSc)患者的骨质疏松性骨折(OFs)发生率(IR)和相关风险因素。
本研究采用了台湾全民健康保险数据库进行队列研究。纳入了 SSc 患者和年龄、性别相匹配的无 SSc 对照者。主要终点为 OF 的首次发生。采用 Cox 比例风险模型分析 SSc 队列中 OFs 的风险因素。
在 1712 例 SSc 患者(77.8%为女性,平均年龄 50.3 岁)中,中位随访时间为 5.2 年,54 例发生了椎体骨折,17 例发生了髋部骨折,7 例发生了桡骨骨折(IR:分别为 6.99、2.18 和 0.90/1000 人年)。与对照组相比,SSc 患者的骨折发生率比值(IRR)(95%CI)分别为椎体骨折 1.78(1.30 至 2.39,p<0.001),髋部骨折 1.89(1.05 至 3.22,p=0.026)。女性患者的整体 OFs 发生率比值(IRR)为 1.74(1.32 至 2.27,p<0.001),男性为 1.06(0.33 至 2.66,p=0.856)。SSc 患者发生髋部骨折的年龄较小(67.2 岁比 75.2 岁,p=0.005),且椎体骨折的 1 年死亡率较高(13%比 3%,p=0.006)。多变量 Cox 回归分析表明,年龄较大、女性、每日泼尼松龙当量>7.5mg 以及用静脉用甲氧氯普胺治疗肠道动力障碍与 OF 相关。
SSc 患者椎体和髋部骨折的发生率较高,尤其是女性、年龄较大、使用大剂量皮质类固醇或有肠道动力障碍的患者。